GENE ONLINE|News &
Opinion
Blog

Solid Tumor
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
FDA Clears Exelixis, Sairopa’s SIRPα Antibody For Solid Tumor Trial
2023-02-14
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
How Patients with dMMR/MSI-H Tumors Can Benefit from Immunotherapy?
2021-09-24
ESMO21: Experts Debate Whether MRD Diagnosis Can Improve Cure Rates in Solid Tumors
2021-09-17
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
R&D
Recent Advances in CAR T-Cell Therapy Development
2021-04-14
R&D
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Weekly Asia Highlights- South Korea and Australia
2020-08-13
1 2
LATEST
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
AstraZeneca’s Latest Moves in Pharmaceuticals in Q1 2024
2024-03-21
AI-Designed Antibodies: A Revolution in Antibody Drug Discovery
2024-03-20
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top